
    
      Visit 1: Informed consent, Inclusion and exclusion criteria, medical history, concomitant
      diseases and medication, physical examination, vital signs, lipid profile, safety lab, urine
      analysis, 12-lead EKG. Diet counseling.

      Run-in phase six weeks. Visit 2 and 3 (5 and 6 weeks after visit 1): Baseline lipids. Visit
      4: Baseline lipid sample, start treatment. Randomization to one of five groups, placebo, 10
      mg, 20 mg, 40 mg, or 80 mg policosanol.

      Visit 5 and 6 (6 and 12 weeks after visit 4): Lipid sample. Safety lab.
    
  